Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review
American Journal of Internal Medicine
Volume 7, Issue 1, January 2019, Pages: 22-26
Received: Feb. 15, 2019; Accepted: Mar. 25, 2019; Published: Apr. 22, 2019
Views 61      Downloads 20
Authors
Firas Ajam, Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Swapnil Patel, Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Anas Alrefaee, Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Dawn Calderon, Department of Cardiology, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Mohammad A. Hossain, Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Arif Asif, Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Article Tools
Follow on us
Abstract
Cardiovascular diseases remains one of the leading causes of mortality worldwide, and causes more than one millions deaths annually in the United States alone. Patients with chronic kidney disease (CKD) are predisposed to different types of heart rhythm abnormalities including but not limited to atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various variations in the cardiovascular system, autonomic nervous system, and various electrolytes abnormalities that open the door for the occurrence of multiple cardiac arrhythmias. Various pathophysiological mechanisms have been suggested in describing the correlation of cardiac arrhythmias in CKD patients. Despite the substantial progress in the management of chronic kidney disease, cardiovascular complications still highly dominant in CKD patient. Thus, reducing mortality from cardiovascular disease and sudden cardiac death in dialysis is a global health challenge. Management of cardiac arrhythmias includes the use of antiarrhythmic drugs, in addition to the use of catheter ablation and cardiac implantable electronic devices. The present review addresses the correlation between chronic kidney disease and different cardiac arrhythmias, the different pathophysiological mechanisms explaining the high risk of arrhythmias in CKD patients, the diagnostic tools used to identify arrhythmias, and the rule of subcutaneous defibrillators in preventing sudden cardiac death in dialysis patients.
Keywords
Cardiac Arrhythmia, Chronic Kidney Disease, Cardiovascular Disease, Cardiac Death
To cite this article
Firas Ajam, Swapnil Patel, Anas Alrefaee, Dawn Calderon, Mohammad A. Hossain, Arif Asif, Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review, American Journal of Internal Medicine. Vol. 7, No. 1, 2019, pp. 22-26. doi: 10.11648/j.ajim.20190701.16
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Zheng, Z., Croft, J. B., Giles, W. H., & Mensah, G. A. (2001). Sudden Cardiac Death in the United States, 1989 to 1998. Circulation, 104(18), 2158-2163. doi:10.1161/hc4301.098254.
[2]
Wanner, C., Herzog, C. A., Turakhia, M. P., Blankestijn, P. J., Carrero, J., Clase, C. M., Winkelmayer, W. C. (2018). Chronic kidney disease and arrhythmias: Highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 94(2), 231-234. doi:10.1016/j.kint.2018.05.005.
[3]
Roberts, P. R., & Green, D. (2011). Arrhythmias in chronic kidney disease. Heart, 97(9), 766-773. doi:10.1136/hrt.2010.208587.
[4]
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. (2016). American Journal of Kidney Diseases, 67(3). doi:10.1053/j.ajkd.2015.12.015.
[5]
Bonato, F. O., & Canziani, M. E. (2017). Ventricular arrhythmia in chronic kidney disease patients. Jornal Brasileiro De Nefrologia, 39(2). doi:10.5935/0101-2800.20170033.
[6]
"Heart Disease Other Related Conditions". cdc.gov. September 3, 2014. Archived from the original on 14 February 2015. Retrieved 19 February 2015.
[7]
Sodickson, A., & Urman, R. D. (n.d.). Opioids. Essential Clinical Anesthesia Review, 133-136. doi:10.1017/cbo9781139584005.038.
[8]
Sawhney, N. S., Anousheh, R., Chen, W., & Feld, G. K. (2009). Diagnosis and Management of Typical Atrial Flutter. Cardiology Clinics, 27(1), 55-67. doi:10.1016/j.ccl.2008.09.010.
[9]
"Types of Arrhythmia". NHLBI. July 1, 2011. Archived from the original on 7 June 2015. Retrieved 7 September 2016.
[10]
"What Is Sudden Cardiac Arrest?". NHLBI. June 22, 2016. Archived from the original on 28 July 2016. Retrieved 16 August 2016.
[11]
Chugh, S. S., Kelly, K. L., & Titus, J. L. (2000). Sudden Cardiac Death With Apparently Normal Heart. Circulation, 102(6), 649-654. doi:10.1161/01.cir.102.6.649.
[12]
Lullo, L. D., Gorini, A., Russo, D., Santoboni, A., & Ronco, C. (2015). Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Medicine, 5(4), 254-266. doi:10.1159/000435838.
[13]
Go, A., Chertow, G., Fan, D., Mcculloch, C., & Hsu, C. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. ACC Current Journal Review, 13(12), 13. doi:10.1016/j.accreview.2004.11.016.
[14]
Zachariah, D., Kalra, P. R., & Roberts, P. R. (2014). Sudden cardiac death in end stage renal disease: Unlocking the mystery. Journal of Nephrology, 28(2), 133-141. Doi: 10.1007/s40620-014-0151-3.
[15]
Kiuchi, M. G., Chen, S., & Pürerfellner, H. (2017). Incidence of ventricular arrhythmic events in CKD patients with ICD. International Journal of Cardiology, 227, 312-317. doi:10.1016/j.ijcard.2016.11.094.
[16]
Hsueh, C., Chen, N. X., Lin, S., Chen, P., Gattone, V. H., Allen, M. R. Moe, S. M. (2014). Pathogenesis of Arrhythmias in a Model of CKD. Journal.
[17]
Cai, Q., Mukku, V., & Ahmad, M. (2014). Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update. Current Cardiology Reviews, 9(4), 331-339. Doi: 10.2174/1573403x10666140214122234.
[18]
Ryan, M. (2014). Faculty of 1000 evaluation for Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). F1000 - Post-publication Peer Review of the Biomedical Literature. doi:10.3410/f.718447086.793497545.
[19]
Dikow, R. (2004). Increased Infarct Size in Uremic Rats: Reduced Ischemia Tolerance? Journal of the American Society of Nephrology, 15(6), 1530-1536. doi:10.1097/01.asn.0000130154.42061.c6.
[20]
Chen PS, Chou CC, Tan AY, Zhou S, Fishbein MC, Hwang C, Karagueuzian HS, Lin SF. The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol. 2006 Dec; 17 Suppl 3:S2-7.
[21]
Ritz, E., & Wanner, C. (2008). The Challenge of Sudden Death in Dialysis Patients. Clinical Journal of the American Society of Nephrology, 3(3), 920-929. doi:10.2215/cjn.04571007.
[22]
Shafi, S., Saleem, M., Anjum, R., Abdullah, W., & Shafi, T. (n.d.). ECG Abnormalities In Patients With chronic kidney disease. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28712176.
[23]
Huang, J., Wei, S., Chen, S., Chang, J., Hung, C., Su, H. Chen, H. (2014). P Wave Dispersion and Maximum P Wave Duration Are Associated with Renal Outcomes in Chronic Kidney Disease. PLoS ONE, 9(7). doi:10.1371/journal.pone.0101962.
[24]
Huang, Y., Chang, Y., Chen, I., Yang, C., Leu, S., Su, H., Shiao, C. (2017). Correction: Heart rate variability during hemodialysis is an indicator for long-term vascular access survival in uremic patients. Plos One, 12(7). doi:10.1371/journal.pone.0181283.
[25]
Thomson, B. J., Mcareavey, D., Neilson, J. M., Winney, R. J., & Ewing, D. J. (1991). Heart rate variability and cardiac arrhythmias in patients with chronic renal failure. Clinical Autonomic Research, 1(2), 131-133. doi:10.1007/bf01826209.
[26]
The role of echocardiographic study in patients with chronic kidney disease. (2015, July 15). Retrieved from http://www.sciencedirect.com/science/article/pii/S0929664615002326.
[27]
Korzets, A., Ori, Y., & Herman, M. (2001, May). Serum potassium levels and atrial fibrillation in haemodialysis patients. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11328938.
[28]
Serum potassium levels and the risk of atrial fibrillation: The Rotterdam Study. (2013, August 23). Retrieved from https://www.sciencedirect.com/science/article/pii/S0167527313015982.
[29]
Roy-Chaudhury, P., Tumlin, J. A., Koplan, B. A., Costea, A. I., Kher, V., Williamson, D., Winkelmayer, W. C. (2018). Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney International, 93(4), 941-951. doi:10.1016/j.kint.2017.11.019.
[30]
Bleyer, A., Hartman, J., Brannon, P., Reeves-Daniel, A., Satko, S., & Russell, G. (2006). Characteristics of sudden death in hemodialysis patients. Kidney International, 69(12), 2268-2273. doi:10.1038/sj.ki.5000446.
[31]
Bakris, G. L., Pitt, B., Weir, M. R., Freeman, M. W., Mayo, M. R., Garza, D. Bushinsky, D. A. (2015). Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease. Jama, 314(2), 151. doi:10.1001/jama.2015.7446.
[32]
Vachharajani, T. J., Salman, L., Costanzo, E. J., Mehandru, S. K., Patel, M., Calderon, D. M. Asif, A. (2017). Subcutaneous defibrillators for dialysis patients. Hemodialysis International, 22(1), 4-8. doi:10.1111/hdi.12577.
[33]
Carrillo, R. G., Garisto, J. D., Salman, L., Merrill, D., & Asif, A. (2010). Contamination of Transvenous Pacemaker Leads Due to Tunneled Hemodialysis Catheter Infection: A Report of 2 Cases. American Journal of Kidney Diseases, 55(6), 1097-1101. doi:10.1053/j.ajkd.2010.01.009.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186